Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using 5-aminosalicylic acid pellets

Journal of Controlled Release

Volumn 38, Issue 1, 1996, Pages 75-84

  Milojevic, Snezana ^a,b   Newton, John Michael ^b   Cummings, John H ^c   Gibson, Glenn R ^c   Louise Botham, R ^d   Ring, Stephen G ^d   Stockham, Mike ^e   Allwood, Mike C ^f  

^a ZOETIS   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d NORWICH RESEARCH PARK   (United Kingdom)

^e British Technology Group   (United Kingdom)

^f UNIVERSITY OF DERBY   (United Kingdom)

Author keywords

5 Aminosalicylic acid; Amylose; Ethylcellulose; In vitro evaluation; Oral colon specific delivery

Indexed keywords

2 PROPANOL; AMYLOSE; CITRIC ACID TRIETHYL ESTER; DICHLOROMETHANE; ETHYL CELLULOSE; EUDRAGIT; EUDRAGIT RS; MACROGOL 300; MESALAZINE; METHANOL; ORGANIC SOLVENT; PLASTICIZER; POLYMER; STARCH; TRIACETIN; UNCLASSIFIED DRUG;

ARTICLE; COLON; COLON FLORA; CONTROLLED STUDY; DISSOLUTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; FERMENTATION; PH; PHARMACEUTICS; PRIORITY JOURNAL; TEMPERATURE;

EID: 0030028174     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(95)00112-3     Document Type: Article

References (28)

1. M.J. Dew, P.J. Hughes, M.G. Lee, B.K. Evans and J. Rhodes, An oral preparation to release drugs in the human colon, Br. J. Clin. Pharmacol. 14 (1982) 405-408.
2. S.N. Rasmussen, S. Bondesen, E.F. Hvidberg, S. Honoré Hansen, V. Binder, S. Halskov and H. Flachs, 5-Aminosalicylic acid in slow-release preparation: Bioavailability, plasma level and excretion in humans, Gastroenterology 83 (1982) 1062-1070.
3. D.F. Evans, G. Pye, R. Bramley, A.G. Clark, T.J. Dyson and J.D. Hardcastle, Measurement of gastro-intestinal pH profiles in normal ambulant human subjects, Gut 29 (1988) 1035-1041.
4. A.K. Azad Khan, J. Piris and S.G. Truelove, An experiment to determine the active therapeutic moiety of sulfasalazine, Lancet 2 (1977) 892-895.
5. K.M. Das, M.A. Eastwood, J.P. McManus and W. Sircus, Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype, N. Engl. J. Med. 289 (1973) 491-495.
6. J. Kopecek, P. Kopeckova, H. Brønsted, R. Rathi, B. Ríhová, P.-Y Yeh and K. Ikesue, Polymers for colon-specific drug delivery, J. Controll. Release 19 (1992) 121-130.
7. D.R. Friend and G.W. Chang, Drug glucosides: Potential prodrugs for colon-specific drug delivery, J. Med. Chem. 28 (1985) 51-57.
8. A. Rubinstein, D. Nakar and A. Sintov, Chondroitin sulphate: a potential biodegradable carrier for colon-specific drug delivery, Int. J. Pharm. 84 (1992) 141-150.
9. H. Brønsted and J. Kopecek, Hydrogels for site specific drug delivery to the colon: In vitro and in vivo degradation, Pharm. Res. 9 (1992) 1540-1545.
10. M. Saffran, G.S. Kumar, C. Savariar, J.C. Burnham, H.S. Williams and D.C. Neckers, A new approach to the oral administration of insulin and other peptide drugs, Science 233 (1986) 1081-1084.
11. M. Ashford, J. Fell, D. Attwood, H. Sharma and P. Woodhead, An evaluation of pectin as a carrier for drug targeting to the colon, J. Control. Release 26 (1993) 213-220.
12. A. Rubinstein, R. Radai, M. Ezra, S. Pathak and J.S. Rokem, In vitro evaluation of calcium pectinate: A potential colon-specific drug delivery carrier, Pharm. Res. 10 (1993) 258-263.
13. S.G. Ring, D.B. Archer, M.C. Allwood and J.M. Newton, Delayed release formulations W091/07946, 1991.
14. V.M. Leloup, P. Colonna and S.G. Ring, α-Amylase adsorption on starch crystallites, Biotechnol. Bioeng. 38 (1991) 127-134.
15. H.N. Englyst and G.T. Macfarlane, Breakdown of resistant and readily digestible starch by human gut bacteria, J. Sci. Food Agric. 37 (1986) 699-706.
16. S.G. Ring, J.M. Gee, M. Whittam, P. Orford and I.T. Johnson, Resistant starch: Its chemical form in foodstuffs and effect on digestibility in vitro, Food Chem. 28 (1988) 97-109.
17. S. Milojevic, Amylose coated pellets for colon-specific drug delivery, Ph.D. Thesis, University of London, 1993.
18. G.K. Adkins and C.T. Greenwood, Isolation of cereal starches in the laboratory, Starch/Stärke 18 (1966) 213-217.
19. G.J. Pesckhe, Pancreatic enzymes (Pancreatin), in: D.D Breimer, D.J.A. Crommelin and K.K. Midha (Eds), Topics in Pharmaceutical Sciences, Proceedings of the 49th International Congress of Pharmaceutical Sciences of F.I.P., Germany, 1989, pp. 129-142.
20. G.T. Macfarlane and H.N. Englyst, Starch utilization by the human large intestinal microflora, J. Appl. Bacteriol. 60 (1986) 195-201.
21. X. Wang and G.R. Gibson, Effects of the in vitro fermentation by bacteria growing in the human large intestine. J. Appl. Bacteriol. 75 (1993) 373-380.
22. G.R. Gibson and X. Wang, Bifidogenic properties of different types of fructo-oligosaccharides, Food Microbiol. 11 (1994) 491-498.
23. S.J. Pirt, Principles of Microbe and Cell Cultivation, Blackwell Scientific Publications, Oxford, 1985.
24. F.N. Christensen, S.S. Davis, J.G. Hardy, M.J. Taylor, D.R. Whalley and C.G. Wilson, The use of gamma scintigraphy to follow the gastro-intestinal transit of pharmaceutical formulation, J. Pharm. Pharmacol. 37 (1985) 91-95.
25. H. Arwidsson, M. Hjelstuen, D. Ingason and C. Graffner, Properties of ethylcellulose films for extended release. III. Influence of process factors when using aqueous dispersions, Acta Pharm. Nord. 3 (1991) 223-228.
26. R.-K. Chang, C.H. Hsiao and J.R. Robinson, A review of aqueous coating techniques and preliminary data on release from a theophylline products, Pharm. Technol. 11 (1987) 56-58.
27. R.C. Rowe, The effect of the molecular weight of ethylcellulose on the drug release properties of mixed films of ethylcellulose and hydroxypropyl methylcellulose, Int. J. Pharm. 29 (1986) 37-41.
28. S.M. Finegold, V.L. Sutter and G.E. Mathisen, Normal indigenous intestinal flora, in: D.J. Hentges (Ed.), Human Intestinal Microflora in Health and Disease, Academic Press, London, 1983, pp. 3-13.